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Epidemiology Unit has taken the investigation of the aetiology of cardiovascular disease in a new direction by exploring how the environment in utero and during infancy determines later risk of coronary heart disease and stroke. The starting point for this research was the realization that although the large variation in current death rates from cardiovascular disease between different areas of England and Wales cannot be explained by the distribution of adult risk factors, these rates paralleled a similarly large variation in infant mortality in the early years of the century.z This observation arose out of a series of analyses of the distribution of cardiovascular disease in Britain. Among the 212 local authority areas of England and Wales, there was a more than twofold variation in mortality from cardiovascular disease during the period 1968-78. The highest rates were found in northern industrial towns and in some of the less affluent rural areas in the north and west of the country. These are the same areas of the country that experienced the highest rates of infant mortality more than half a century earlier. Figure 1 illustrates the remarkably close correlation between cardiovascular mortality during 1968-78 and neonatal mortality in the past. 2 ,3 The horizontal axis on Figure 1 refers to neonatal mortality around the time of birth of the generation whose cardiovascular death rates are shown on the vertical axis.
In the past, high neonatal mortality was associated with high maternal mortality. Places with high rates from both neonatal and maternal mortality were characterized by a high incidence of low birthweight and by poor nutrition and health of pregnant women.s-" This strong geographical link between current cardiovascular death rates and past patterns of low birthweight and poor maternal nutrition stimulated investigation of the idea that adverse environmental influences operating during fetal and infant life might initiate pathophysiological mechanisms that ultimately lead to cardiovascular disease.
Evidence of programming from animal experiments
Although nobody doubts that the phenotypic expression of genes that have been present since fertilization may be delayed until an organism is mature, the concept that the consequences of early environmental influences may also have delayed and long-lasting effects is less familiar. But the results of numerous experiments in animals demonstrate that transient events in early life have permanent and profound effects on physiology and metabolism. Such effects may remain latent until the animal is adult.6-12 One example of this is that rats weaned onto a low protein diet for a brief period subsequently show a permanently impaired insulin response to glucose.t? This impaired response is likely to reflect persisting damage to pancreatic beta cells, which develop during late fetal life and infancy.
The phenomenon whereby a long-term alteration in structure or metabolism is induced by a relatively brief stimulus is known as programming. Poor nutrition and other influences have permanent programming effects if they occur at sensitive critical periods of early development. Critical periods probably correspond to phases of rapid cell replication. 13 One well-studied example of a critical period in development is the sexual differentiation of the rodent brain. A female rat injected with a few micrograms of testosterone propionate during the first four days after birth develops normally until puberty. Only then does it become apparent that the hypothalamic neuronal substrate that mediates the cyclic release of gonadotrophins has been irreversibly altered and, despite adequate ovarian and pituitary function, Whether these ideas about the programming effect of the fetal and infant environment are applicable to the pathogenesis of cardiovascular disease in humans is now being systematically explored in studies of middle-aged and elderly adults whose birth measurements and infant growth were recorded.
The first follow-up studies
A nationwide search of archives and hospitals in Britain led to the discovery of several sets of records. From 1911 onwards, every baby born in the county of Hertfordshire was weighed at birth, visited periodically by a health visitor throughout the first year, and weighed again at one year of age. 15 Because records of these visits have survived, it is possible to trace men and women born 60 or more years ago and to relate their early measurements to the later occurrence of illness and death, and to the levels of known risk factors for cardiovascular disease. Similar long-term follow-up studies are being carried out in Preston'« and Sheffield!" where, from early in the present century, unusually detailed measurements on all newborn babies were made in maternity hospitals.
Mortality from coronary heart disease
The first study in Hertfordshire was of 5600 men born in the eastern part of the county between 1911 and 1930. 15 The size of the sample was later increased and Figure 2 shows results for 8175 men. Those who weighed 181b (8.2 kg) or less at one year of age had death rates from coronary heart disease which were almost three times greater than among those who weighed 27 Ib (12.3 kg) or more. Death rates fell progressively with increasing weight at one year. There were similar, though less strong, trends with birthweight. A later study in Sheffield confirmed the relation between impaired fetal growth and risk of death from cardiovascular disease.'? and similar trends have recently been found in women born in Hertfordshire (Barker DJP, unpublished observations).
These findings prompted questions about the mechanisms that might be responsible. A series of studies have shown that a number of known risk factors for coronary heart disease, including blood pressure, lipid metabolism, levels of haemostatic variables and glucose tolerance, are susceptible to the programming effects of the environment in early life.
Hypertension and arterial compliance
Hypertension is, of course, long established as an important risk factor for coronary heart disease. A large amount of evidence now points to impaired fetal growth as an important determinant of adult levels of blood pressure. Table 1 shows that systolic blood pressure in elderly men and women born and still living in Hertfordshire There was no association of adult blood pressure with weight at one year, independent of birthweight, in the men and women in the Hertfordshire study nor was infant growth found to be related to blood pressure in the Brompton study of 1895 children followed up from birth to 10 years.s' It seems that high blood pressure is initiated by processes associated with reduced growth in utero rather than events in postnatal life. High blood pressure is not confined to people whose intrauterine growth retardation, defined by birthweight at the lowest centiles, was severe. The relation between blood pressure and fetal growth is present throughout the range of birthweights.
An analysis of a longitudinal study of children and three follow-up studies of adults has demonstrated that, with advancing age, the relation between birthweight and current blood pressure becomes stronger. 22 The results of the analysis are summarized in Figure 3 . The vertical axis gives, for each age, the strength of the association between birthweight and systolic blood pressure, expressed as the fall in pressure associated with a 1 kg increase in birth weight. The size of the fall increases with age. One interpretation of this trend is that an effect initiated in utero is slowly amplified over the lifetime of an individual. The existence of two components, initiation and amplification, in the aetiology of essential hypertension was first proposed by Folkow.P Both components may have their origin in fetal development. At present, we know little about the mechanisms that underlie them. A possible initiating process could be changes in fetal blood flow, perhaps resulting from perfusion of a large placenta, since, as we shall discuss later, large placental size in relation to fetal size is a strong predictor of blood pressure in adults.
The feedback mechanism that amplifies the initiating effects with age could depend on progressive changes in the structure, physical properties and compliance of blood vessels.> Experiments indicate that the DNA content of the rat aorta is affected by growth inhibition during fetal developments' and that a short period of hypertension in young animals induces irreversible alterations in the mechanical properties of the arterial wal1. 26 In humans and in animals vascular structure and compliance change with haemodynamic load.s? Arterial compliance determines pulse pressure and changes in pulse pressure produce changes in the scleroprotein content of the vessel wall that, in turn, affect arterial compliance. This is one possible mechanism by which adaptions in the fetal pattern of circulation could alter the structure of blood vessels in adults and perpetuate and amplify raised systolic blood pressure from infancy to old age.
We have estimated arterial compliance in more than 200 men and women, now aged around 50 years, using a noninvasive method that directly Table 2 Mean pulse wave velocity (m/sec) in femoral-tibial arterial segments in men and women aged around 50 years according to measurements made at birth measures the transit time of the blood flow pulse and so allows the velocity of the pulse pressure wave to be calculated. The velocity of the pulse pressure wave is inversely related to the square root of the compliance of the blood vessel wall;28 a higher pulse wave velocity indicates a lower arterial wall compliance. The results of a preliminary analysis are shown in Table 2 .
The mean pulse wave velocity in femoral-tibial arterial segment is consistently greater in people whose weight, length and abdominal and head circumferences at birth were small. Although pulse wave velocities were faster in people with higher systolic blood pressure, the relation between pulse wave velocity and measurements made at birth was still apparent after adjustment for current blood pressure. Similar, though less strong, relations were seen between pulse wave velocities in the aorta and small measurements at birth.
These findings give support to the idea that the mechanisms that amplify raised blood pressure Abdominal circumference at birth (in) have their origins in fetal life and that they involve structural changes in the arterial wall.
Lipid metabolism
Studies of serum lipids among adults in Hertfordshire and Sheffield show that raised serum total and low-density lipoprotein (LDL) concentrations are associated with specific patterns of impaired fetal growth and the type and duration of infant feeding. Detailed description of these findings is beyond the scope of this review. In summary, men and women who had a small abdominal circumference at birth had raised serum concentrations of total and low-density lipoprotein cholesterol and of apolipoprotein B.29 This association was independent of social class, current body weight, cigarette smoking and alcohol consumption. Small abdominal circumference is an indication of failure of growth of abdominal viscera, including the liver, in late gestation. The processes by which impaired liver growth could alter low density lipoprotein cholesterol metabolism are unknown but one possibility is that the activity of low density lipoprotein receptors is permanently reduced. We have also found that bottle feeding and delayed weaning are associated with raised serum concentrations of total and lowdensity lipoprotein cholesterol.w These discoveries had been foreshadowed by experiments in animals. In baboons, breast-feed~ng lead~to. a highe~ratio of low density to high density lipoprotein cholesterol in adult life than is found in formula-fed baboons. 11, 31 Interference with cholesterol metabolism during development has been shown to have permanent effects on rates of synthesis and excretiont-and it is known that, in rats, the timing of weaning also exerts a long lasting influence on lipid metabolism. 33
Plasma fibrinogen concentrations
Studies of plasma fibrinogen concentration, the strongest single predictor of cardiovascular disease, have shown that high concentrations are found in men whose weight gain during infancy was low or who were short at birth in relation to their head circumference.s- Table 3 shows mean according to weight at one year concentrations of fibrinogen according to weight at one year of age in men aged 59-70. Adjustment for variables known to affect fibrinogen concentrations (smoking habit, alcohol consumption, body mass index and waist-hip ratio) did not affect the strength of the relation with infant growth.
The association between plasma fibrinogen concentrations and shortness at birth indicates that fetal growth as well as growth in infancy has an important influence. Shortness at birth is thought to indicate impaired fetal growth during late gestationv which is a time of rapid liver development.
The intra-uterine environment
The conclusion that blood pressure, lipid metabolism and levels of haemostatic factors are programmed in fetal life poses a number of questions. What are the influences which alter fetal growth? How does the fetus and placenta respond to these influences? And how does this response operate to produce long-term effects? Fetal growth is determined by the intra-uterine environmentin particular, by the supply of nutrients and oxygen. In addition, the mother is herself able to modulate fetal growth. This is shown by the strong positive relation between mothers' height and babies' birthweight. The maternal constraint of fetal growth has also been shown in embryo transfer and cross-breeding experiments: a fetus transferred to a larger uterus will achieve a larger birth size.w
We have recently found that maternal pelvic size has an effect on blood pressure of her offspring; children of mothers whose intercristal pelvic diameter was small tend to have higher systolic blood pressure in adult life. However, measurements of the baby at birth predict adult disorders independently of maternal pelvic size.!? Nutritional influences on the intra-uterine environment as well as the constraint that the similar to those found in adults.V This observation cannot be attributed to a confounding variable acting in adult life.
Another possible reason for the close link between early growth and cardiovascular disease is that the genes that determine low weight gain in utero and during infancy also determine cardiovascular disease in adult life. But this also is an unlikely explanation because birthweight does not seem to be strongly genetically determined. Comparisons of the birthweights of half-siblings show that while those related through the mother tend to have similar birthweights, those related through the father do not. 38 Studies of the birthweights of first born children of mothers and their daughters similarly suggest that genetic factors play only a small part in determining birthweight. 39 Nor, except in rare instances of premature familial coronary heart disease, is there much evidence of a major genetic component in most cases of cardiovascular disease. One explanation that has been put forward to account for some of the findings described above is that reduced growth in utero and during infancy is merely an indicator of continuing exposure to an adverse environment in childhood and adult life. It is this later environment, they suggest, that produces the effects that we have attributed to impaired early development. 36 This explanation is unlikely to be correct. Relations between reduced early growth and mortality from cardiovascular disease and levels of cardiovascular risk factors are consistent, strong and graded. The size of the relative risks should be compared with the much smaller risks associated with adult lifestyle. The relative risk of coronary heart disease associated with heavy cigarette smoking, for example, is around 2.0. Further, studies of four-year-old children have shown associations between birthweight, and placental weight and blood pressure The set of obstetric records from Sharoe Green H?spital, Preston, dating from the first part of this century gave us an opportunity to study groups of men and women whose measurements at birth were recorded in detail.w Table  4 shows the mean systolic pressure of 327 men and women aged around 50 living in Preston today. They were all born after 38 completed weeks of gestation. The men and women are arranged by three birthweight groups, and in four groups of placental weight. There is, as e~pec~ed, a fall in blood pressure associated With Increasing birthweight. There is also añ nsuspected increase in blood pressure with Increasing placental weight. Those people with systo~ic pressures of 150 mmHg or more were, at the time of birth, small in relation to the size of their placentas.
A disproportionately large placenta may be ã onsequence of maternal undernutrition. It occurs In babies whose mothers were anaemic during pregnancy41.42 and it can be produced experi-!Uentally in sheep by depriving the ewe of food In early pregnancy.43.44 Maternal undernutritioñ ay be a decisive influence in determining high ood pressure in the next generation.
Conclusions
e relations between early growth and carlovascular disease and its risk factors are co . d' ntInUous. Death rates from cardiovascular f Isease and the prevalence of its risk factors all progressively up to the highest values of birthweight and weight at one year. If the criteria for successful fetal growth include adult health and longevity, these findings reinforce the view that babies with significant intra-uterine growth retardation need not necessarily be 'light-for-gestational age'.45 Intra-uterine growth retardation seems to be widespread. It affects many babies whose birthweights are within the normal range, not just a few babies who can be recognized clinically by their unusually small size and high risk of perinatal complications and death.
We need to know more about the effects of intra-uterine growth retardation on different organs and systems in the human fetus. Understanding the factors that modulate the growth of the fetus and permanently programme its metabolism may be the key to the effective prevention of cardiovascular disease in adult life.
